ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceutical Chemicals

AGC will expand Spanish API facility

by Michael McCoy
April 10, 2020 | APPEARED IN VOLUME 98, ISSUE 14

 

09814-buscon13-agc.jpg
Credit: AGC
AGC is adding labs and production capacity at this facility in Malgrat, Spain.

Japan’s AGC will invest “a few billion yen”—roughly $25 million—to expand its active pharmaceutical ingredient plant in Malgrat, Spain. AGC acquired the plant a year ago from Boehringer Ingelheim as part of its push into the drug services business. AGC says it will expand the number of production lines from 11 to 14, add a micronization facility, and build a research facility at the site.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment